Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 13 crawled time : 16:20 save search
Sypris Reports Third Quarter Results
Published: 2021-11-10 (Crawled : 16:20) - ir.sypris.com
SYPR 4 | $1.59 1.27% 0.95% 14K
|
Producer Manufacturing
|
| O: -1.61%
H: 0.0%
C: -10.63%
results report
Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update
Published: 2021-11-08 (Crawled : 16:20) - ocutx.gcs-web.com
OCUL | News | $5.075 -2.78% -2.86% 3.5M
|
Health Technology
|
| O: -0.56%
H: 11.33%
C: 8.07%
financial results ocular results
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
Published: 2021-11-09 (Crawled : 16:20) - ir.catabasis.com
ATXS | $9.8 0.51% 0.61% 1.5M
|
Manufacturing
|
| O: -3.35%
H: 0.0%
C: 0.0%
conference therapeutics
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
Published: 2021-11-09 (Crawled : 16:20) - ir.kalvista.com
KALV | News | $11.44 -1.12% -0.96% 290K
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
conference
Alkermes Announces Receipt of Notices of Partial Termination From Janssen Pharmaceutica
Published: 2021-11-08 (Crawled : 16:20) - investor.alkermes.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
ALKS | $24.07 0.92% 0.87% 1.2M
|
Health Technology
|
| O: -7.74%
H: 2.51%
C: -8.24%
Alkermes to Take Part in the Stifel Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 16:20) - investor.alkermes.com
ALKS | $24.07 0.92% 0.87% 1.2M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
conference
Akero Therapeutics to Present at the Jefferies London Healthcare Conference
Published: 2021-11-09 (Crawled : 16:20) - ir.akerotx.com
AKRO | $20.79 0.15% 0.14% 710K
|
Health Technology
|
| O: -0.7%
H: 1.13%
C: -5.39%
conference therapeutics
Liberty All-Star® Growth Fund, Inc. October 2021 Monthly Update
Published: 2021-11-13 (Crawled : 16:20) - prnewswire.com
ADSK | $217.13 0.29% 0.28% 1.2M
|
Technology Services
| Email alert
Add to watchlist
SITE | $157.0 0.68% 0.0% 240K
|
Distribution Services
| Email alert
Add to watchlist
AMZN S | $177.23 1.49% 1.47% 28M
|
Retail Trade
| Email alert
Add to watchlist
NTRA | News S | $88.61 3.91% 3.8% 970K
|
Health Services
| Email alert
Add to watchlist
CHGG A | $6.82 -3.81% 0.59% 1.5M
|
Commercial Services
| Email alert
Add to watchlist
WDAY S | $253.53 0.52% 0.52% 900K
|
Technology Services
| Email alert
Add to watchlist
MEG 4 | $39.04 -2.89% 0.0% 380K
|
Commercial Services
| Email alert
Add to watchlist
SPSC | $168.64 1.9% 2.04% 220K
|
Technology Services
| Email alert
Add to watchlist
SBNY | News | $3.5 -2.51% 0.0% 250K
|
Finance
| Email alert
Add to watchlist
CWST | $94.09 0.71% 0.75% 160K
|
Industrial Services
| Email alert
Add to watchlist
PGNY | $33.06 1.1% 1.06% 660K
|
Commercial Services
| Email alert
Add to watchlist
growth
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a pH-Selective Anti-VISTA Antibody, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 16:20) - investors.senseibio.com
SNSE | $0.9309 -4.03% -1.04% 66K
|
|
| O: -1.15%
H: 0.0%
C: 0.0%
preclinical immunotherapy therapy cancer antibody iot pre-clinical
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
Published: 2021-11-11 (Crawled : 16:20) - ir.therapeuticsmd.com
TXMD | News | $1.88 1.08% 1.06% 19K
|
Health Technology
|
| O: -1.19%
H: 0.49%
C: -6.71%
BNTX | News | $88.01 1.38% 1.36% 340K
|
Health Technology
|
| O: 0.87%
H: 0.99%
C: -0.65%
ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights
Published: 2021-11-09 (Crawled : 16:20) - ir.chemocentryx.com
CCXI | News | $51.99 -0.04%
|
Health Technology
|
| O: 2.6%
H: 7.01%
C: -2.61%
financial results results
ChemoCentryx to Participate in Two Upcoming Investor Conferences
Published: 2021-11-10 (Crawled : 16:20) - ir.chemocentryx.com
CCXI | News | $51.99 -0.04%
|
Health Technology
|
| O: 2.6%
H: 7.01%
C: -2.61%
conference
AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-08 (Crawled : 16:20) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.55%
H: 3.57%
C: -1.23%
financial results results
AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences
Published: 2021-11-10 (Crawled : 16:20) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -1.11%
H: 1.83%
C: -0.14%
conference
Intensity Therapeutics Reports Promising Overall Survival Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab or Ipilimumab to Treat Solid Tumors, at The Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
Published: 2021-11-13 (Crawled : 16:20) - prnewswire.com
BMY | $49.14 0.43% 0.12% 6.4M
|
Health Technology
| Email alert
Add to watchlist
INTS | $3.9 0.52% 2.51% 7.1K
|
| Email alert
Add to watchlist
immunotherapy solid tumors therapy results cancer
HYZN INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Hyzon Motors Inc.
Published: 2021-11-13 (Crawled : 16:20) - prnewswire.com
HYZN | $0.5743 -4.6% -4.57% 500K
|
| Email alert
Add to watchlist
deadline
EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD
Published: 2021-11-13 (Crawled : 16:20) - prnewswire.com
EYPT | News | $16.95 -3.97% -3.95% 1.4M
|
Health Technology
| Email alert
Add to watchlist
treatment eye phase 1 positive trial
Cyclerion Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
Published: 2021-11-09 (Crawled : 16:20) - ir.cyclerion.com
CYCN | $3.05 -12.86% -12.54% 3.5K
|
Health Technology
|
| O: 0.72%
H: 1.79%
C: -6.09%
financial results results
Vaccinex, Inc. to Present at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-11-10 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $4.94 1.65% -2.76% 5.9K
|
Health Technology
|
| O: -1.46%
H: 3.47%
C: -1.49%
immunotherapy therapy cancer vaccine
New Results for Zilebesiran Presented at AHA Scientific Sessions 2021
Published: 2021-11-13 (Crawled : 16:20) - alnylam.com
ALNY | $145.79 0.96% 0.94% 400K
|
Health Technology
| Email alert
Add to watchlist
results
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.